NVAX : Summary for Novavax, Inc. - Yahoo Finance

U.S. Markets closed

Novavax, Inc. (NVAX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.26-0.01 (-0.79%)
At close: 4:00PM EDT
People also watch
BCRXINOHEBDVAXARRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.27
Open1.28
Bid1.26 x 500
Ask1.29 x 500
Day's Range1.25 - 1.29
52 Week Range1.16 - 8.49
Volume1,985,821
Avg. Volume6,256,339
Market Cap341.77M
Beta2.14
PE Ratio (TTM)-1.22
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 3 Beaten-Up Biotech Stocks: Are They Bargains?
    Motley Fool4 days ago

    3 Beaten-Up Biotech Stocks: Are They Bargains?

    Attention bargain shoppers: Three small-cap biotech stocks are now available at knockdown prices.

  • Novavax, Inc. :NVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube5 days ago

    Novavax, Inc. :NVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Novavax, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Novavax, Inc. – Sarepta Therapeutics, Inc., Agenus Inc., BioCryst Pharmaceuticals, Inc., Emergent BioSolutions Inc., Astrazeneca PLC Sponsored ADR, Novartis AG Sponsored ADR, Achillion Pharmaceuticals, Inc., NanoViricides, Inc., Pfizer Inc. ... Read more (Read more...)

  • Accesswire9 days ago

    Trade Volume Can Speak a Lot About Momentum of a Stock

    NEW YORK, NY / ACCESSWIRE / March 16, 2017 / Two biotech firms, Rexahn Pharmaceuticals and Novavax are low priced stocks with a number of interested investors, scoring close to 8 million and 6 million ...